Effect of a transaminase inhibitor on the transport of cytosolic reducing equivalents into mitochondria.
D000332:Aerobiosis; D000693:Anaerobiosis; D000818:Animals; D003523:Cycloserine / Q000494:pharmacology*; D003593:Cytoplasm / Q000187:drug effects / Q000378:metabolism*; D000431:Ethanol / Q000494:pharmacology; D005420:Flavoproteins / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D000637:Transaminases / Q000037:antagonists & inhibitors
D005420:Flavoproteins; D007773:Lactates; D011773:Pyruvates; D009243:NAD; D000431:Ethanol; D003523:Cycloserine; D000637:Transaminases